(Q45849818)

English

Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection

scientific article published in December 1990

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

A S Lok

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

C L Lai

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

E K Leung

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

language of work or name

0 references

publication date

1 December 1990

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

12

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

1266-1270

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

21 January 2018

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

21 January 2018

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoblastoid interferon therapy of chronic HBV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese children

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (Intron A)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of anti-IFN-alpha antibody titres during interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to human leucocyte interferons in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

The detection of antibodies to recombinant interferon alfa-2a in human serum

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of neutralization of interferon by antibody

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.1840120603

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45849818&oldid=2086277211"